Medicinal Products

Incresync

Name Incresync
Active Substance alogliptin / pioglitazone
Prescription na recept
Type of prescription ponovljivi recept
Distribution u ljekarni
ATC Code A10BD09
Medicinal product marketed in the Croatia Da
Educational materials
for healthcare professionals
Vodič za propisivanje pioglitazona-verzija 1
Popratni dopis_Incresync

Note

The medicinal product has been authorised via centralised procedure in all Member States of the European Union based on the European Medicines Agency's expert opinion. Additional information on the medicinal product can be found under the following link:https://www.ema.europa.eu/en/medicines/human/EPAR/incresync

The marketing authorisation has been granted by the European Commission. All marketing authorisations of the European Commission can be found under the following link: http://ec.europa.eu/health/documents/community-register/html/index_en.htm

Back